Patent details
EP2994155 Title: TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY
Basic Information
- Publication number:
- EP2994155
- PCT Application Number:
- US2014037377
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP147941140
- PCT Publication Number:
- WO2014182955
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY
- French Title of Invention:
- CIBLAGE DE L'INTERACTION ENTRE UN EGFR ET UN SGLT1 POUR LA CANCÉROTHÉRAPIE
- German Title of Invention:
- TARGETING DER EGFR-SGLT1-INTERAKTION ZUR KREBSTHERAPIE
- SPC Number:
Dates
- Filing date:
- 08/05/2014
- Grant date:
- 23/12/2020
- EP Publication Date:
- 16/03/2016
- PCT Publication Date:
- 13/11/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/12/2020
- EP B1 Publication Date:
- 23/12/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 08/05/2021
- Expiration date:
- 08/05/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/12/2020
- Name:
- The University of Houston System
- Address:
- 316 E. Cullen, Houston, TX 77204-2015, United States (US)
Inventor
- Name:
- WEIHUA, Zhang
- Address:
- United States (US)
Priority
- Priority Number:
- 201361821028 P
- Priority Date:
- 08/05/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/70; A61K 38/10; A61P 35/00; C07K 7/08; C07K 14/00;
Publication
European Patent Bulletin
- Issue number:
- 202052
- Publication date:
- 23/12/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|